Thema
Exenatide
9P1872D4OL
11
Hypoglycemic Agents
11
Journal Article
11
Peptides
11
Venoms
11
Research Support, Non-U.S. Gov't
6
2ZM8CX04RZ
5
Comparative Study
5
Insulin Glargine
5
Insulin, Long-Acting
4
Type 2 diabetes
4
Blood Glucose
3
Insulin
3
insulin glargine
3
ADA treatment guidelines
2
Absolute benefit
2
Diabetes mellitus
2
GLP-1
2
Glucagon-Like Peptide-1 Receptor
2
Hypoglycemia
2
Macrovascular outcomes
2
Number needed to treat
2
Observational Study
2
Pharmaco-epidemiology
2
Physical Activity
2
Physical Activity Behavior
2
Pioglitazone
2
Pyrazines
2
Randomized Controlled Trial
2
Sitagliptin
2
Sitagliptin Phosphate
2
TS63EW8X6F
2
Thiazolidinediones
2
Triazoles
2
X4OV71U42S
2
839I73S42A
1
89750-14-1
1
Clinical Trial, Phase III
1
Dipeptidyl-Peptidase IV Inhibitors
1
GLP1R protein, human
1
Glucagon-Like Peptide 1
1
Glycated Hemoglobin A
1
Liraglutide
1
Multicenter Study
1
Receptors, Glucagon
1
albuminuria
1
diabetes
1
eGFR
1
exenatide
1
mehr ...